Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mTOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01582191
What this trial is testing

Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Advanced Malignant NeoplasmMetastatic Malignant NeoplasmRecurrent Malignant Neoplasm+1 more
M.D. Anderson Cancer Center 123
Not applicableWithdrawnNCT07329088
What this trial is testing

Isoleucine Addition Treatment Effects in a Controlled Diet Study

Who this might be right for
Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)Metabolic Syndrome (MetS)Obesity & Overweight
Jean L. Fry
Testing effectiveness (Phase 2)Study completedNCT01567488
What this trial is testing

Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET

Who this might be right for
Gastrointestinal Neoplasms
Grupo Espanol de Tumores Neuroendocrinos 43
Testing effectiveness (Phase 2)Study completedNCT02091531
What this trial is testing

Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Memorial Sloan Kettering Cancer Center 9
Very early researchStudy completedNCT02646319
What this trial is testing

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Who this might be right for
Advanced Malignant NeoplasmCervical Squamous Cell CarcinomaEndometrial Carcinoma+29 more
Mayo Clinic 2
Early research (Phase 1)Study completedNCT01624766
What this trial is testing

Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers

Who this might be right for
Advanced Malignant NeoplasmMetastatic Malignant NeoplasmRecurrent Malignant Neoplasm+1 more
M.D. Anderson Cancer Center 57
Large-scale testing (Phase 3)Ended earlyNCT01952847
What this trial is testing

Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 77
Early research (Phase 1)Looking for participantsNCT05949658
What this trial is testing

Rapalog Pharmacology (RAP PAC) Study

Who this might be right for
Aging
University of Wisconsin, Madison 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07662174
What this trial is testing

Ventricular mTOR Inhibition to Prevent Hydrocephalus After Brain Hemorrhage

Who this might be right for
Post-hemorrhagic Hydrocephalus (PHH)
Massachusetts General Hospital 15
Large-scale testing (Phase 3)UnknownNCT05833815
What this trial is testing

Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

Who this might be right for
Gallbladder Cancer
Banaras Hindu University 56
Early research (Phase 1)Study completedNCT01122199
What this trial is testing

Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors

Who this might be right for
Neoplasm Metastases
Shadia Jalal 27
Early research (Phase 1)Study completedNCT01248494
What this trial is testing

PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Vanderbilt-Ingram Cancer Center 72
Early research (Phase 1)Active Not RecruitingNCT01087554
What this trial is testing

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

Who this might be right for
Advanced Cancer
M.D. Anderson Cancer Center 249
Testing effectiveness (Phase 2)Ended earlyNCT01020305
What this trial is testing

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerProstatic NeoplasmsCastrate-resistant Prostate Cancer (CRPC)+3 more
Sandy Srinivas 5
Very early researchWithdrawnNCT04019769
What this trial is testing

Glutamine Supplementation in People With Immune Dysregulation

Who this might be right for
EczemaMTOROC1 Signaling
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT06341998
What this trial is testing

Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children

Who this might be right for
Germ Cell TumorYolk Sac Tumor
Shandong First Medical University 32
Early research (Phase 1)Study completedNCT01536054
What this trial is testing

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer+21 more
Roswell Park Cancer Institute 7
Early research (Phase 1)Study completedNCT01026402
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 172
Testing effectiveness (Phase 2)Study completedNCT00409994
What this trial is testing

Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer

Who this might be right for
Rectum Cancer
Maastricht Radiation Oncology 44
Testing effectiveness (Phase 2)UnknownNCT02279758
What this trial is testing

A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors

Who this might be right for
Well-differentiated Neuroendocrine Tumors
Instituto do Cancer do Estado de São Paulo 30
Next Page